Trial Profile
Usual risk factors for fracture associated with increased risk of fragility fractures in females exposed to Depo-Provera.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2017
Price :
$35
*
At a glance
- Drugs Medroxyprogesterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- 02 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism